UBS analyst David Dai lowered the price target on Nurix (NASDAQ: NRIX) to $26.00 (from $30.00) while maintaining a Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE